Search Type: drug or dietary supplement name
Search Term: clopidogrel (PLAVIX)

Drug Profiles | Worst Pills, Best Pills Newsletter Articles | Additional Information from Public Citizen

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a secondary subject of discussion
  • cilostazol (PLETAL)
    We list this drug as a Do Not Use drug because it has limited effectiveness and may lead to an increased risk of death.

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Overview of the Antiplatelet Drug Prasugrel (EFFIENT) [hide all summaries]
    (May 2018)
    Prasugrel is an oral antiplatelet drug that was approved by the FDA in 2009 as an add-on treatment to aspirin to prevent clots from forming that may cause a heart attack or stroke in certain patients with coronary artery disease. Learn why we recommend avoiding this medication.
  • Spironolactone: Review of a ‘Water Pill’ [hide all summaries]
    (March 2017)
    Spironolactone is a diuretic (water pill) that has been used for decades to treat certain patients with high blood pressure, heart failure, swelling (water retention) and other conditions. Find out who is most likely to benefit from using this drug and who should avoid it because of its dangerous adverse effects.
  • Is XARELTO Really the 'Right Move' for Patients With Blood Clots or Risk for Stroke? [hide all summaries]
    (April 2016)
    If you watch TV, you likely have seen ads touting the advantages of the new oral antico-agulant (blood thinner) rivaroxaban (XARELTO). Learn why we have designated this drug as Do Not Use for Seven Years (until at least July 2018).
  • Year in Review: Troubling New Drug Approvals in 2015 [hide all summaries]
    (March 2016)
    Learn about six new drugs approved by the FDA in 2015 that Worst Pills, Best Pills News has identified as dangerous or ineffective. The drugs include two for lowering high cholesterol levels, one for removing excess fat below the chin, and another for treating gout, among others.
  • New Warnings on Common Heartburn Drugs: Too Little — and, for Some, Too Late [hide all summaries]
    (February 2015)
    After a more than three-year delay and a Public Citizen lawsuit filed against the FDA, the agency finally responded to our petition for stronger label warnings on a class of medications, known as proton pump inhibitors, commonly used to treat heartburn. This article discusses the new warnings that the FDA has required in response to our petition.
  • Adding NSAIDS or Aspirin to Anticoagulants Increases Bleeding Danger [hide all summaries]
    (December 2014)
    If you are one of the millions of patients in the U.S. who take blood thinners on a long-term basis to prevent potentially harmful clots in the heart, veins or arteries, read this article to learn why you should avoid taking NSAIDS or aspirin unless absolutely necessary.
  • Niacin Ineffective in Treating Cardiovascular Disease [hide all summaries]
    (August 2013)
    A new study casts serious doubt on the usefulness of long-popular niacin products to treat or prevent cardiovascular disease.
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • Don't Get Sold By Drug Ads on TV, Says Study [hide all summaries]
    (May 2007)
    Not only does this study find that consumer drug ads are not educational, it also says that the ads may oversell the benefits of the drugs and could put the public health in danger. For example, of the 24 drugs included in this advertising study, seven are listed as Do Not Use in Worst Pills, Best Pills publications. You should not rely on direct-to-consumer television advertisements as a source of drug information.
  • Adverse Drug Reactions Cause 1.4 Million Emergency Room Visits in 2004 and 2005 [hide all summaries]
    (January 2007)
    An estimated 701,547 patients were treated for adverse drug reactions in emergency rooms each year in 2004 and 2005, totaling 1.4 million visits to the emergency room. Of these, an estimated 117,318 patients were hospitalized each year. According to the study. 18 drugs were each, either independently or in combination with other drugs, implicated in one percent or more of the estimated adverse drug events. These drugs are listed in the table that accompanies this article along with the annual estimates of adverse drug events.

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion
  • [hide all summaries]
    Agency experts should be required to give presentations at all future Food and Drug Administration (FDA) advisory committee meetings discussing specific products, Public Citizen said in a petition filed today.
  • [hide all summaries]
    Comments by Elizabeth Barbehenn submitted to FDA Guidance for Industry on Clinical Lactation Studies (HRG Publication #1735)

SHOW primary search results for clopidogrel (PLAVIX)